416 related articles for article (PubMed ID: 11500913)
21. The liver-enriched inhibitory protein isoform of CCAAT/enhancer-binding protein beta, but not nuclear factor-kappaB, mediates the transcriptional inhibition of beta-casein by tumor necrosis factor-alpha.
Zhang H; Zhang H; Lee L; Ip MM
Endocrinology; 2004 Jun; 145(6):2833-44. PubMed ID: 14976147
[TBL] [Abstract][Full Text] [Related]
22. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
Bae EJ; Kim SG
Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
[TBL] [Abstract][Full Text] [Related]
23. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
Bundy LM; Sealy L
Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
[TBL] [Abstract][Full Text] [Related]
24. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
[TBL] [Abstract][Full Text] [Related]
25. Lactogenic hormones and tenascin-C regulate C/EBPalpha and beta in mammary epithelial cells.
Cella N; Chiquet-Ehrismann R; Hynes NE
J Cell Biochem; 2000 Jan; 76(3):394-403. PubMed ID: 10649437
[TBL] [Abstract][Full Text] [Related]
26. Role of specific CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells.
Gheorghiu I; Deschênes C; Blais M; Boudreau F; Rivard N; Asselin C
J Biol Chem; 2001 Nov; 276(47):44331-7. PubMed ID: 11559710
[TBL] [Abstract][Full Text] [Related]
27. Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress.
Li Y; Bevilacqua E; Chiribau CB; Majumder M; Wang C; Croniger CM; Snider MD; Johnson PF; Hatzoglou M
J Biol Chem; 2008 Aug; 283(33):22443-56. PubMed ID: 18550528
[TBL] [Abstract][Full Text] [Related]
28. The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse.
Bégay V; Baumeier C; Zimmermann K; Heuser A; Leutz A
Sci Rep; 2018 May; 8(1):8417. PubMed ID: 29849099
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.
Zahnow CA; Younes P; Laucirica R; Rosen JM
J Natl Cancer Inst; 1997 Dec; 89(24):1887-91. PubMed ID: 9414177
[TBL] [Abstract][Full Text] [Related]
30. CCAAT/enhancer binding proteins in normal mammary development and breast cancer.
Zahnow CA
Breast Cancer Res; 2002; 4(3):113-21. PubMed ID: 12052253
[TBL] [Abstract][Full Text] [Related]
31. Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis.
Bégay V; Smink JJ; Loddenkemper C; Zimmermann K; Rudolph C; Scheller M; Steinemann D; Leser U; Schlegelberger B; Stein H; Leutz A
J Mol Med (Berl); 2015 Jan; 93(1):39-49. PubMed ID: 25401168
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: implication of LIP in pro-survival functions.
Saint-Auret G; Danan JL; Hiron M; Blache C; Sulpice E; Tendil S; Daveau M; Gidrol X; Salier JP
J Hepatol; 2011 Jun; 54(6):1185-94. PubMed ID: 21145827
[TBL] [Abstract][Full Text] [Related]
33. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells.
Eaton EM; Hanlon M; Bundy L; Sealy L
J Cell Physiol; 2001 Oct; 189(1):91-105. PubMed ID: 11573208
[TBL] [Abstract][Full Text] [Related]
34. Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBPbeta.
Carmona MC; Hondares E; Rodríguez de la Concepción ML; Rodríguez-Sureda V; Peinado-Onsurbe J; Poli V; Iglesias R; Villarroya F; Giralt M
Biochem J; 2005 Jul; 389(Pt 1):47-56. PubMed ID: 15762841
[TBL] [Abstract][Full Text] [Related]
35. C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage.
Welm AL; Timchenko NA; Darlington GJ
Mol Cell Biol; 1999 Mar; 19(3):1695-704. PubMed ID: 10022857
[TBL] [Abstract][Full Text] [Related]
36. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
[TBL] [Abstract][Full Text] [Related]
37. Osteoprotegerin ligand induces beta-casein gene expression through the transcription factor CCAAT/enhancer-binding protein beta.
Kim HJ; Yoon MJ; Lee J; Penninger JM; Kong YY
J Biol Chem; 2002 Feb; 277(7):5339-44. PubMed ID: 11726661
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice.
Grimm SL; Contreras A; Barcellos-Hoff MH; Rosen JM
J Biol Chem; 2005 Oct; 280(43):36301-9. PubMed ID: 16120603
[TBL] [Abstract][Full Text] [Related]
39. Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland.
Hutt JA; O'Rourke JP; DeWille J
J Biol Chem; 2000 Sep; 275(37):29123-31. PubMed ID: 10867011
[TBL] [Abstract][Full Text] [Related]
40. C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells.
Bundy L; Wells S; Sealy L
Mol Cancer; 2005 Dec; 4():43. PubMed ID: 16371159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
